1. Vairo F, Federhen A, Baldo G, Riegel M, Burin M, Leistner-Segal S, et al. Diagnostic and treatment strategies in mucopolysaccharidosisvi. Dovepress journal: Th Application of Clinical Genetics. 2015;8:245-55.
2. Bahnar F, Schiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative Incidence Rates of the Mucopolysacharidosis in Germany. J Inherit Metab Dis. 2005;28:1011-7.
3. Malm G, Lund A, Mansson J, Heiberg A. Mucopolysacharidoses in the Scandinavian Contries: Incidence and Prevalence. ActaPaediatr. 2008; 97(11):1577-81.
4. Mojtahedzade F, RashidiGhader F, Alaei AR, Tale A. A Case Report of Mucopolysaccharidosis type Maroteaux-Lamy. Mazandaran University of Medical Sciences Journal 2006;56:136-42.
5. HashemiTayer A, Talebi R. Mucopolysaccharidoses (Maroteaux-Lamy):A case Report. Arak Medical University Journal(AMUJ). 2012;15(61):119-25.
6. Vassili V, Helen N, Paul H, Sean T. Mucopolysacchaidosis VI. Orphanet Journal of Rare Diseases. 2010:5-10.
9. Koseoglu S, Harmatz P, Turbeville S, Nicely H. Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy. Int Ophthalmol. 2009;29(4):267-9.
8. Gomes B, Souza Gda S, Viana G. Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential. Case Rep Ophthalmol. 2013;3(1):104-12.
10. Cardoso-Santos A, Azevedo A, Fagondes S, Burin M, Giugliani R, Schwartz I. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength. J Pediatr (Rio J). 2008;84(2):130-5.
11. Arslan N, Mavi A, Kalkan S. Findings of hepatobiliary scintigraphy and liver biopsy in Maroteaux-Lamy syndrome presenting as neonatal cholestasis. Pediatr Int 2006; 48(5): 498-500
12. Thumler A, Miebach E, Lampe C. Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series. J Inherit Metab Dis. 2012;35(6):1071-9.
12. Choudhury I, Tilak MA, Kumar Patra A. A Rare Case of Mucopolysaccharidosis. Ind J Clin Biochem. Jan-Mar 2014;29(1):101-6.
13. Giugliani R, Harmatz P, Wraith J. Management guidelines for mucopolysaccharidosis VI. Pediatrics. 2007;120(2):405-18.
14. Tootoonchi P, Tootoonchi AS. A review of congenital metabolic diseases, clinical manifestations, diagnosis and treatment. 1, editor. Tehran Tehran University of Medical Sciences Publications Office and Science Survey; 2012.
15. Roubicek M, Gehler J, Spranger J. The clinical spectrum of alphaiduronidasedeficiency. Am J MedGenet. 1985;20:471-81.
16. Golda A, Jurecka A, Tylki-Szymanska A. Cardiovascular Manifestations of Mucopolysaccaridosis Type VI (Maroteaux-Lamy syndrome). Int J Cardiol. 2011;11(4):213.
18. Koomanaee S, Taghavi Z. Mucopolysaccharidosis VI, A Case Report. J Of Guilan University Of Medical Sciences. 2014;2(89):83-9.
)